Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advance Access & Delivery (AA&D) is a non-profit global health organization founded in 2014 to address barriers to high-quality healthcare and life-saving medicines, particularly for economically and socially marginalized populations. The organization focuses on designing and implementing community-based models of care, with a primary emphasis on eliminating tuberculosis (TB) through the Zero TB Initiative and Zero TB Cities Project. AA&D also operates programs in harm reduction, providing access to opioid overdose reversal medications like naloxone, and manages integrated care initiatives for HIV, diabetes, and hepatitis. By partnering with local governments, academic institutions, and civil society, AA&D works to eliminate double standards in global health and deliver comprehensive, person-centered care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Access & Delivery Institute.